Filter posts

Tony Coelho: A Patient Advocate's Perspective on Paying for Value

Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House …

Tekmira Pharmaceuticals Ebola Drug Gets Nod From FDA

The U.S. Food and Drug Administration has authorized Canada’s Tekmira Pharmaceuticals to provide an experimental drug …

Differences Between Establishing Value for Approval Versus Coverage?

Yes, but maybe not irreconcilable. Many of the educational sessions on the first day of …